Back to Companies
ArriVent BioPharma, Inc.
AVBPNasdaqCIK: 0001868279
Over the 10 most recent insider filings, ArriVent BioPharma, Inc. (AVBP) has seen activity from 10 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $13.0M sold, net sales of $13.0M. HILLHOUSE INVESTMENT MANAGEMENT, LTD. (10% Owner) is the most active by dollar volume, and the single largest transaction was $13.0M by HILLHOUSE INVESTMENT MANAGEMENT, LTD.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$39.6M
Purchases
$0
Sales
$13.0M
Unique Insiders
10
Recent Insider Trades
10 loaded
| Jun 22 | AVBP ArriVent BioPharma, Inc. | Nolet Chris | Director | Award | $430.5K |
| Jun 22 | AVBP ArriVent BioPharma, Inc. | Parsey Merdad | Director | Award | $430.5K |
| Jun 22 | AVBP ArriVent BioPharma, Inc. | Peterson Kristine | Director | Award | $430.5K |
| Jun 22 | AVBP ArriVent BioPharma, Inc. | Hohneker John | Director | Award | $430.5K |
| Feb 4 | AVBP ArriVent BioPharma, Inc. | Lutzker Stuart | President of R&D, Director | Award | $3.4M |
| Feb 4 | AVBP ArriVent BioPharma, Inc. | Kung Winston | Chief Financial Officer | Award | $3.2M |
| Feb 4 | AVBP ArriVent BioPharma, Inc. | Kastenmayer James Paul | General Counsel | Award | $2.9M |
| Feb 4 | AVBP ArriVent BioPharma, Inc. | LaChapelle Robin | Chief Operating Officer | Award | $2.9M |
| Feb 4 | AVBP ArriVent BioPharma, Inc. | Yao Zhengbin | President and CEO, Director | Award | $12.5M |
| Feb 3 | AVBP ArriVent BioPharma, Inc. | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10% Owner | Sell | $13.0M |
10 filings